{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:35:40Z","timestamp":1762418140386,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.remn.2018.09.004","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T23:36:11Z","timestamp":1546990571000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparaci\u00f3n entre la PET\/TC con 18F-DOPA y la PET\/TC con 68Ga-DOTATOC para la localizaci\u00f3n del paraganglioma maligno extra-adrenal y el feocromocitoma"],"prefix":"10.1016","volume":"38","author":[{"given":"A.S.","family":"Kroiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Uprimny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.L.","family":"Shulkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Frech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Jazbec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.P.","family":"Girod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Url","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Riechelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Sprinzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fraedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.J.","family":"Virgolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2018.09.004_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10689-004-2155-y","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"4","author":"Brink","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1016\/j.remn.2018.09.004_bib0135","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2018.09.004_bib0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00188673","article-title":"Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities","volume":"21","author":"Van Gils","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.remn.2018.09.004_bib0145","first-page":"365","article-title":"Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison","volume":"40","author":"Maurea","year":"1996","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.remn.2018.09.004_bib0150","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00259-003-1115-3","article-title":"18F-DOPA positron emission tomography for the detection of glomus tumours","volume":"30","author":"Hoegerle","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2018.09.004_bib0155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/MNM.0b013e328345a340","article-title":"Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma","volume":"32","author":"Rufini","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2018.09.004_bib0160","first-page":"32","article-title":"In vivo demonstration of enzyme activity in endocrine pancreatic tumors: Decarboxylation of carbon-11-DOPA to carbon-11-dopamine","volume":"37","author":"Bergstr\u00f6m","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2018.09.004_bib0165","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00259-012-2087-y","article-title":"Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: A meta-analysis","volume":"39","author":"Treglia","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2018.09.004_bib0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12149-017-1162-7","article-title":"Compared to 123I-MIBG SPECT\/CT, 18F-DOPA PET\/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma","volume":"31","author":"Kroiss","year":"2017","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.remn.2018.09.004_bib0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: Comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2018.09.004_bib0180","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1210\/jc.2003-030262","article-title":"Somatostatin receptor subtypes in human pheochromocytoma: Subcellular expression pattern and functional relevance for octreotide scintigraphy","volume":"88","author":"Mundschenk","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2018.09.004_bib0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-0031-1299712","article-title":"Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma","volume":"44","author":"Timmers","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.remn.2018.09.004_bib0190","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","article-title":"EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"39","author":"Ta\u00efeb","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2018.09.004_bib0195","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","article-title":"Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma","volume":"49","author":"Ilias","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2018.09.004_bib0200","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","article-title":"Declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"284","author":"World Medical Association","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.remn.2018.09.004_bib0205","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/MNM.0b013e3282f1753d","article-title":"A fully automated synthesis for the preparation of 68Ga-labelled peptides","volume":"28","author":"Decristoforo","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2018.09.004_bib0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0883-2889(90)90191-I","article-title":"Remote, semiautomated production of 6-[18F]fluoro-l-dopa for human studies with PET","volume":"41","author":"Luxen","year":"1990","journal-title":"Int J Rad Appl Instrum A"},{"key":"10.1016\/j.remn.2018.09.004_bib0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000184855","article-title":"Mallorca consensus conference participants European Neuroendocrine Tumor Society. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological examinations","volume":"90","author":"Sundin","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.remn.2018.09.004_bib0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12022-008-9047-x","article-title":"Pheochromocytoma: Time to stamp out \u201cmalignancy\u201d?","volume":"19","author":"Tischler","year":"2008","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.remn.2018.09.004_bib0225","article-title":"Performance of 68Ga-DOTA-conjugated somatostatin receptor targeting peptide PET in detection of pheochromocytoma and paraganglioma: A systematic review and meta-analysis","author":"Han","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2018.09.004_bib0230","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00259-010-1720-x","article-title":"Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine","volume":"38","author":"Kroiss","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2018.09.004_bib0235","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s00259-013-2548-y","article-title":"A retrospective comparison between 68Ga-DOTA-TOC PET\/CT and 18F-DOPA PET\/CT in patients with extra-adrenal paraganglioma","volume":"12","author":"Kroiss","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2018.09.004_bib0240","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2018.09.004_bib0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00259-014-2892-6","article-title":"(68)Ga-DOTATOC PET\/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT\/CT","volume":"42","author":"Kroiss","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2018.09.004_bib0250","first-page":"315","article-title":"A rare case of a 123I-MIBG SPECT\/CT positive, but 68Ga-DOTA-TOC PET\/CT negative pheochromocytoma of the bladder","volume":"37","author":"Kroiss","year":"2018","journal-title":"Rev Esp Med Nucl Imagen Mol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X1830163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X1830163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:31:37Z","timestamp":1762417897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X1830163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2253654X1830163X"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2018.09.004","relation":{},"ISSN":["2253-654X"],"issn-type":[{"type":"print","value":"2253-654X"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparaci\u00f3n entre la PET\/TC con 18F-DOPA y la PET\/TC con 68Ga-DOTATOC para la localizaci\u00f3n del paraganglioma maligno extra-adrenal y el feocromocitoma","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}